Cabaletta Bio

Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer to Lead Global Launch Strategy for Rese-Cell Therapy

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced the appointment of Steve Gavel as Chief Commercial Officer, effective immediately. Gavel will oversee all aspects of commercial strategy and execution …

Cabaletta Bio Appoints Steve Gavel as Chief Commercial Officer to Lead Global Launch Strategy for Rese-Cell Therapy Read More


Medical

Epista Life Science Launches Major Clinical Data Remediation Program to Support Global Biopharma Transformation

KING OF PRUSSIA, PA — Epista Life Science has announced the launch of one of the pharmaceutical industry’s largest clinical data remediation programs, a multi-phase initiative covering more than 800 …

Epista Life Science Launches Major Clinical Data Remediation Program to Support Global Biopharma Transformation Read More